《大行報告》里昂:舜宇(02382.HK)面臨手機需求弱挑戰 指車用芯片短缺需時解決
里昂發表研究報告指出,舜宇(02382.HK)9月份的手機和車載鏡頭出貨量表現疲弱,料短期內其手機業務或仍面臨需求疲弱影響,而車用芯片短缺問題需時解決,惟相信待問題緩解後,有助於為明年的車載鏡頭業務增長設定一個較低的基數,維持對其「買入」評級,目標價291元,相當於2022財年預測市盈率的37倍。
該行解釋對舜宇估值基礎,予其2022財年的攝像頭模組業務預測市盈率達25倍,略高於同業,而手機攝像頭與其他模組製造平均預測市盈率為23倍,反映公司於同業的領先地位及潛在增長,另評估其車載鏡頭業務預測市盈率達75倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.